Release Notes:
Data Element
Version 2010B
| Data Element Name: | Fibrinolytic Administration |
|---|
| Collected For: | AMI-7, AMI-7a, AMI-8, AMI-8a, |
|---|
| Definition: | The patient received primary fibrinolytic therapy during this hospital stay. Fibrinolytic therapy is the administration of a pharmacological agent intended to cause lysis of a thrombus (destruction or dissolution of a blood clot). |
|---|
| Suggested Data Collection Question: | Was primary fibrinolytic therapy received during this hospital stay? |
|---|
| Format: | | Length: | 1 |
|---|
| Type: | Alphanumeric |
|---|
| Occurs: | 1 |
|---|
|
|---|
| Allowable Values: |
Y (Yes) Primary fibrinolytic therapy administered during hospital stay.
N (No) No primary fibrinolytic therapy administered during hospital stay, or unable to determine from medical record documentation.
|
|---|
| Notes for Abstraction: |
- In the event the patient was brought to the hospital via ambulance and fibrinolytic therapy was infusing at the time of arrival, select “Yes.”
- In the event the patient was brought to the hospital via ambulance and fibrinolytic therapy was infused during transport but was completed at the time of hospital arrival, select “No.”
|
|---|
| Suggested Data Sources: |
- Emergency department record
- Nursing notes
- Discharge summary
- Medication administration record (MAR)
- ICU/nursing flow sheets
- IV flow sheets
|
|---|
| Additional Notes: |
|
|---|
| Guidelines for Abstraction: |
|---|
| Inclusion | Exclusion |
- Refer to Appendix C, Table 1.5 for a comprehensive list of Fibrinolytic Agents.
|
- Fibrinolytics given during or after a PCI
|
|
Fibrinolytic Administration
Specifications Manual for Joint Commission National Quality Core Measures (2010B)
Discharges 10-01-10 (4Q10) through 03-31-11 (1Q11)
|